BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31693922)

  • 21. Flavonol and imidazole derivatives block HPV16 E6 activities and reactivate apoptotic pathways in HPV⁺ cells.
    Yuan CH; Filippova M; Krstenansky JL; Duerksen-Hughes PJ
    Cell Death Dis; 2016 Jan; 7(1):2060. PubMed ID: 26794656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of papillomavirus protein function in cervical cancer cells by intrabody targeting.
    Griffin H; Elston R; Jackson D; Ansell K; Coleman M; Winter G; Doorbar J
    J Mol Biol; 2006 Jan; 355(3):360-78. PubMed ID: 16324714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The E6AP binding pocket of the HPV16 E6 oncoprotein provides a docking site for a small inhibitory peptide unrelated to E6AP, indicating druggability of E6.
    Zanier K; Stutz C; Kintscher S; Reinz E; Sehr P; Bulkescher J; Hoppe-Seyler K; Travé G; Hoppe-Seyler F
    PLoS One; 2014; 9(11):e112514. PubMed ID: 25383876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperthermia Selectively Targets Human Papillomavirus in Cervical Tumors via p53-Dependent Apoptosis.
    Oei AL; van Leeuwen CM; ten Cate R; Rodermond HM; Buist MR; Stalpers LJ; Crezee J; Kok HP; Medema JP; Franken NA
    Cancer Res; 2015 Dec; 75(23):5120-9. PubMed ID: 26573798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of p53 codon 72 genotypes and clinical outcome in human papillomavirus-infected lung cancer patients.
    Chen SP; Hsu NY; Wu JY; Chen CY; Chou MC; Lee H; Cheng YW
    Ann Thorac Surg; 2013 Apr; 95(4):1196-203. PubMed ID: 23522190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
    Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
    Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronan-CD44 interaction promotes HPV 16 E6 oncogene-mediated oropharyngeal cell carcinoma survival and chemoresistance.
    Bourguignon LYW; Earle C; Shiina M
    Matrix Biol; 2019 May; 78-79():180-200. PubMed ID: 30077625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BCCIPβ facilitates p53 ubiquitination via binding with E6 protein in high-risk HPV positive head and neck squamous cell carcinoma.
    Wang F; Wang J; Wang J; Zhang L; Fu H; Li J; Tian T; Zuo J; Lv W; Ma X
    Biochem Biophys Res Commun; 2020 Aug; 529(3):685-691. PubMed ID: 32736693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of screening systems for drugs against human papillomavirus-associated cervical cancer: based on E6-E6AP binding.
    Cho Y; Cho C; Joung O; Lee K; Park S; Yoon D
    Antiviral Res; 2000 Sep; 47(3):199-206. PubMed ID: 10974372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations.
    Wen X; Li D; Zhang Y; Liu S; Ghali L; Iles RK
    Anticancer Drugs; 2012 Mar; 23(3):280-7. PubMed ID: 22245994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
    Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
    Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma.
    Xie X; Piao L; Bullock BN; Smith A; Su T; Zhang M; Teknos TN; Arora PS; Pan Q
    Oncogene; 2014 Feb; 33(8):1037-46. PubMed ID: 23474763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomics Analysis of Andrographolide-Induced Apoptosis via the Regulation of Tumor Suppressor p53 Proteolysis in Cervical Cancer-Derived Human Papillomavirus 16-Positive Cell Lines.
    Udomwan P; Pientong C; Tongchai P; Burassakarn A; Sunthamala N; Roytrakul S; Suebsasana S; Ekalaksananan T
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.
    Munagala R; Kausar H; Munjal C; Gupta RC
    Carcinogenesis; 2011 Nov; 32(11):1697-705. PubMed ID: 21859835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation.
    Crook T; Tidy JA; Vousden KH
    Cell; 1991 Nov; 67(3):547-56. PubMed ID: 1657399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides.
    Stutz C; Reinz E; Honegger A; Bulkescher J; Schweizer J; Zanier K; Travé G; Lohrey C; Hoppe-Seyler K; Hoppe-Seyler F
    PLoS One; 2015; 10(7):e0132339. PubMed ID: 26151636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pitx2a binds to human papillomavirus type 18 E6 protein and inhibits E6-mediated P53 degradation in HeLa cells.
    Wei Q
    J Biol Chem; 2005 Nov; 280(45):37790-7. PubMed ID: 16129685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest.
    Foster SA; Demers GW; Etscheid BG; Galloway DA
    J Virol; 1994 Sep; 68(9):5698-705. PubMed ID: 8057451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.